Literature DB >> 4122234

Protamine--antagonist to heparin.

L B Jaques.   

Abstract

Protamine is used for titration of heparin in vitro for diagnosis of hemorrhagic states and for neutralization of heparin in vivo to terminate heparinization. The protamine equivalent varies with the heparin preparation, conditions of testing and, in vivo, with the amount of heparin present in the circulation. The latter depends on time after administration and the hemodynamic and metabolic state of the patient. Protamine, when injected rapidly, will release histamine and agglutinate platelets. Bleeding (spontaneous hemorrhage) demonstrates a multiple breakdown of hemostatic mechanisms due to surgical stress, drugs, exposure of the blood to foreign surfaces, etc. Simple rules for the amount of protamine required for an individual patient based on clinical judgement will be satisfactory in most cases. When hemostasis is not achieved, it must be appreciated that heparin and protamine are only part of a complex deteriorating situation.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4122234      PMCID: PMC1941450     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  16 in total

1.  The elimination from plasma of intravenous heparin. An experimental study on dogs and humans.

Authors:  P OLSSON; H LAGERGREN; S EK
Journal:  Acta Med Scand       Date:  1963-05

2.  [Exact determination of the actual blood heparin content at the moment when it is neutralized by polybrene or protamine sulfate].

Authors:  C RABY; M SERVELLE
Journal:  Hemostase       Date:  1962-12

3.  ANAPHYLAXIS IN THE LIVERLESS DOG AND OBSERVATIONS ON THE ANTICOAGULANT OF ANAPHYLACTIC SHOCK.

Authors:  E T Waters; J Markowitz; L B Jaques
Journal:  Science       Date:  1938-06-24       Impact factor: 47.728

Review 4.  The pharmacology of heparin and heparinoids.

Authors:  L B Jaques
Journal:  Prog Med Chem       Date:  1967

5.  Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.

Authors:  S Niewiarowski; V Gurewich
Journal:  J Lab Clin Med       Date:  1971-04

6.  Comparative neutralization of lung- and mucosal-derived heparin by protamine sulfate using in vitro and in vivo methods.

Authors:  L R Lowary; F A Smith; E Coyne; N W Dunham
Journal:  J Pharm Sci       Date:  1971-04       Impact factor: 3.534

7.  Is protamine a clinically important anticoagulant? A negative answer.

Authors:  N Ellison; A J Ominsky; H Wollman
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

8.  The laboratory control of intravenous heparin therapy.

Authors:  D W Davies
Journal:  Med J Aust       Date:  1971-11-13       Impact factor: 7.738

9.  The kinetics of heparin.

Authors:  J W Estes
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

10.  Total cardiopulmonary bypass, myocardial contractility, and the administration of protamine sulfate.

Authors:  A Gourin; R L Streisand; J H Stuckey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-01       Impact factor: 5.209

View more
  12 in total

Review 1.  Bioresponsive nanosensors in medical imaging.

Authors:  Eyk Schellenberger
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

2.  Non cytotoxic guinea-pig mesenteric mast cell stimulation by protamine.

Authors:  C Augusto; L O Lunardi; I Vugman
Journal:  Agents Actions       Date:  1987-12

3.  Inhibitory effects of atropine, protamine, and their combination on hepatitis A virus replication in PLC/PRF/5 cells.

Authors:  E Biziagos; J M Crance; J Passagot; R Deloince
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Safety and benefits of protamine administration to revert anticoagulation soon after coronary angioplasty. A meta-analysis.

Authors:  Giuseppe De Luca; Guido Parodi; David Antoniucci
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

5.  Enhanced Photoacoustic Detection of Heparin in Whole Blood via Melanin Nanocapsules Carrying Molecular Agents.

Authors:  Wonjun Yim; Kathryn Takemura; Jiajing Zhou; Jingcheng Zhou; Zhicheng Jin; Raina M Borum; Ming Xu; Yong Cheng; Tengyu He; William Penny; Bill R Miller; Jesse V Jokerst
Journal:  ACS Nano       Date:  2021-12-28       Impact factor: 18.027

6.  Water-Borne Endovascular Embolics Inspired by the Undersea Adhesive of Marine Sandcastle Worms.

Authors:  Joshua P Jones; Monika Sima; Ryan G O'Hara; Russell J Stewart
Journal:  Adv Healthc Mater       Date:  2016-01-25       Impact factor: 9.933

7.  Effect of dietary protamine on lipid metabolism in rats.

Authors:  Ryota Hosomi; Kenji Fukunaga; Hirofumi Arai; Seiji Kanda; Toshimasa Nishiyama; Munehiro Yoshida
Journal:  Nutr Res Pract       Date:  2010-12-28       Impact factor: 1.926

8.  IgE antibodies increase honeybee venom responsiveness and detoxification efficiency of mast cells.

Authors:  Philipp Starkl; Nicolas Gaudenzio; Thomas Marichal; Laurent L Reber; Riccardo Sibilano; Martin L Watzenboeck; Frédéric Fontaine; André C Mueller; Mindy Tsai; Sylvia Knapp; Stephen J Galli
Journal:  Allergy       Date:  2021-05-06       Impact factor: 14.710

9.  Functional differences between protamine preparations for the transfection of mRNA.

Authors:  Natalia Teresa Jarzebska; Severin Lauchli; Christoph Iselin; Lars E French; Pal Johansen; Emmanuella Guenova; Thomas M Kündig; Steve Pascolo
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

10.  Genetic screening for single-cell variability modulators driving therapy resistance.

Authors:  Eri Arai; Sareh Bayatpour; Connie L Jiang; Eduardo A Torre; Lauren E Beck; Benjamin L Emert; Sydney M Shaffer; Ian A Mellis; Mitchell E Fane; Gretchen M Alicea; Krista A Budinich; Ashani T Weeraratna; Junwei Shi; Arjun Raj
Journal:  Nat Genet       Date:  2021-01-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.